conferences in September. The sessions will both be conducted in a
question and answer format and will include a company overview and a
review of the company’s growth opportunities.
The sessions will take place as follows:
September 5, at 1:55 p.m. ET– Baird’s 2012 Healthcare Conference in
New York City; and
September 10, at 11:45 a.m. ET– Morgan Stanley Global Healthcarein
New York City.
A live webcast of each session will be accessible through the Investor
section of the company’s website at www.amagpharma.com.
Following the conferences, the webcasts will be archived on the
on the development and commercialization of a therapeutic iron compound
to treat iron deficiency anemia. For additional company information,
please visit www.amagpharma.com.
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303